Phentermine, a short-term appetite suppressant, and semaglutide, a GLP-1 receptor agonist approved for long-term weight management, work through different mechanisms
The industry has consolidated and some manufacturers have little incentive to solve shortages because cheap generics generate thin profits
Discontinuing the medication without consulting your healthcare provider could negatively impact your blood sugar control and overall treatment plan
This medication represents a promising advancement in the treatment of obesity and overweight conditions, providing a tool for those struggling with weight management
However, their effectiveness in achieving skin-lightening or similar benefits is still a subject of debate within the scientific community
In clinical practice, physicians put more emphasis on the presence or absence of similarity between the biochemical profile of the patient and known biochemical profile of the suspected toxicity (e.g., cholestatic damage in amoxycillin-clauvonic acid )